A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.

The season is over for Washington Wizards forward Cam Whitmore, as he recovers from a frightening injury setback. “Washington ...

Having had a front seat view to the struggles faced by patients suffering from poor circulation, two young medical doctors have partnered to make compression therapy more affordable and accessible to ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...

Dr. Sina Bari, a practicing surgeon and AI healthcare leader at data company iMerit, has seen firsthand how ChatGPT can lead ...